Hand Eczema: Delgocitinib Takes on Established Treatments
AMSTERDAM — The Janus kinase inhibitor delgocitinib may be a better or comparable choice for treating hand eczema than some more established therapies, suggested the results of two separate studies presented during the late-breaking sessions at the …